Results
Find here news and results of the project and subprojects.
December 2023
November 2022
From March 15-17, 2023, the “First National Conference on Infectious Disease Modeling” was held in Berlin by the BMBF-funded Modeling Network for Serious Infectious Diseases (MONID), in which RESPINOW participated as one of the research consortia. More than 100 national and international scientists used the meeting for networking and exchange. In addition, during an internal RESPINOW session, current challenges in the individual subprojects could be presented, jointly discussed and worked on.
Press release MONID
Press release BMBF
Press release Zuse Institute Berlin
November 2022
On 02. and 03 November 2022, the kick-off meeting of RESPINOW took place as a hybrid event at the HZI in Braunschweig. Project participants from all 10 institutions met offline and online to discuss planned projects and concrete implementation within the subprojects as well as the common interfaces and nodes of the subprojects. Many thanks to all participants for the successful and exciting meeting.
Press release HZI
October 2022
The second interim analysis in the IMMUNEBRIDGE project represents a data pooling of data from several studies that conducted surveys of immunity, vaccination coverage, and occurred reported infections with SARS-CoV-2 in Germany from June to early September in the summer of 2022. The results are intended to inform modeling consortia to enable the appropriate groups to use current population data for parameterization. The data were presented to the BMBF in October and published here: https://zenodo.org/record/7177592#.Y00D4HZBxaR
August 2022
As part of a BMBF-funded adhoc project of the Network for University Medicine (NUM) (IMMUNEBRIDGE), the new survey conducted in the fast population panel MuSPAD for RESPINOW has been extended in June and July 2022. In total, more than 9000 people participated again in a survey and more than 3000 came again for a blood draw at one of the study centers. The corresponding data on protection from infection and protection from a severe course of SARS-CoV-2 transmission, together with other cohorts, were made available to the BMBF modeling consortia in August in a dataset: https://zenodo.org/record/6968574#.YygfsXZBwuU